http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5858965-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-825
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
filingDate 1995-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55c1691eb2a75a3e44a6e15cebbe2622
publicationDate 1999-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5858965-A
titleOfInvention Pharmaceutical compositions for the treatment of autoimmune diseases comprising the B-oligomer of pertussis toxin or its subunits
abstract PCT No. PCT/US95/16450 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Dec. 4, 1995 PCT Pub. No. WO96/17620 PCT Pub. Date Jun. 13, 1996The invention provides the use of a protein selected from the B-oligomer of pertussis toxin, an individual subunit S2, S3, S4 or S5 thereof, or a combination of the subunits, for the preparation of pharmaceutical compositions comprising them for the treatment of autoimmune diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013003786-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021069302-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010291089-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6245883-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018028623-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849961-B2
priorityDate 1994-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5453272-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9219646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4845036-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022

Total number of triples: 28.